SPE and LC–ESI–MS for Quantitative Analysis of Mitiglinide in Human Plasma in a Bioequivalence Study

Liquid chromatography–electrospray ionization mass spectrometry has been used for rapid, selective, and sensitive quantitative analysis of mitiglinide in human plasma. Sample pretreatment involved solid-phase extraction from plasma with gliclazide as internal standard. Separation was performed on a C₁₈ column (150 × 2.0 mm) with 71:29 (v/v) acetonitrile–water (containing 0.1% formic acid and 0.2 mmol L^?1 ammonium acetate) as mobile phase at a flow rate of 0.2 mL min^?1. The method was validated then successfully applied to a clinical bioequivalence study of mitiglinide in 20 healthy volunteers after oral administration.     

Determination of Palmatine in Rabbit Plasma by RP-HPLC with Solid-Phase Extraction

A rapid and specific reversed-phase high performance liquid chromatography (RP-HPLC) method for the determination of palmatine in rabbit plasma has been developed and validated. The chromatographic separation was performed on a C₁₈ column at 40 °C. The mobile phase, delivered at 1.0 mL min^?1, consisted of acetonitrile/phosphate buffer (pH 3.0) 40:60 (v/v). The detection wavelength was set at 345 nm. Palmatine and internal standard (IS) berberine were extracted from plasma by solid-phase extraction using C18 cartridges. Linearity was confirmed in the concentration range of 0.01 to 5 μg mL^?1, the inter-day and intra-day RSDs were within 10.0, the recoveries of palmatine ranged from 93.1 to 110.3, and the limit of detection (LOD, S/N > 3) was 0.002 μg mL^?1. The method is applicable to the determination of palmatine in rabbit plasma after intravenous administration of palmatine.     

Development and Validation of LC Coupled with SPE for Simultaneous Determination of Lamivudine, Oxymatrine and its Active Metabolite Matrine in Dog Plasma

A simple and highly selective method, based upon solid-phase extraction (SPE), ion-pair HPLC and UV absorbance detection, was developed and validated to determine lamivudine, oxymatrine and its active metabolite matrine in dog plasma. The analytes and famotidine (internal standard) were simultaneously extracted from plasma samples by SPE, and separated on a C18 column. The mobile phase consisted of acetonitrile-water (13:87, v/v, 5 mmol L^?1 sodium heptanesulfonate, at pH 3.2). The lower limit of quantification of the method was 0.1 mg L^?1 for these analytes. The linear calibration curves of the analytes were obtained in the concentration range of 0.1–40 mg L^?1. This method was successfully applied to the quantitative determination of plasma concentration of lamivudine, oxymatrine and its active metabolite matrine in dogs after single oral co-administration of 5.0 mg kg^?1 lamivudine and 30.0 mg kg^?1 oxymatrine.     

Determination of Iodate in Iodized Salt by Reversed-Phase High-Performance Liquid Chromatography with UV Detection

A method for the determination of iodate was developed by reversed-phase high-performance liquid chromatography with UV detection. Iodate was converted to iodine, which was separated from the matrix using a reversed-phase Ultrasphere C₁₈ column (250 × 4.6 mm, 5 μm) with methanol-1 mmol L^?1 H₃PO₄ (20:80, v/v) as mobile phase at 1.00 mL min^?1 and UV detection at 224 nm. The calibration graph was linear from 0.05 μg mL^?1 to 5.00μg mL^?1 for iodine with a correlation coefficient of 0.9994 (n=7). The detection limit was 0.01 μg mL^?1. The method was successfully applied to the determination of iodate in iodized salt. The recovery was from 96% to 101% and the relative standard deviation was in the range of 1.5% to 2.9%.     

Quantification of Teprenone in Human Plasma by HPLC Coupled to Mass Spectrometry: Application to a Bioequivalence Study

A rapid, sensitive, and specific method has been developed for quantification of teprenone (TEP) in human plasma. The analytes were isolated from plasma by liquid–liquid extraction with t-butyl methyl ether. The extracts were analyzed by high-performance liquid chromatography coupled to mass spectrometry (HPLC–MS); gefarnate was used as internal standard (IS). HPLC separation of the analytes was performed on a C₁₈ column with 1:54:45 (v/v) 1% aqueous acetic acid–methanol–acetonitrile as mobile phase; the flow rate was 0.2 mL min^?1. The compounds were ionized by atmospheric-pressure chemical ionization (APCI). Calibration plots for TEP were linear in the range 20.0–2000.0 ng mL^?1; correlation coefficients were >0.9981. The average extraction efficiency for TEP was >67%, method recovery was >95%, the limit of detection (LOD) was 1.0 ng mL^?1, and the intraday and interday coefficients of variation were <7%. This HPLC–MS procedure was used to assess the bioequivalence of TEP tablet and capsule formulations. A single 150-mg dose of each formulation was administered to 18 healthy male volunteers. The study was conducted using an open, randomized, two-period crossover design with a 1-week wash-out interval. Because the 90% CI for C _max and the ratios of the AUCs were all within the 80–125% range stipulated by the US Food and Drug Administration, it was concluded that the TEP tablet and capsule formulations were bioequivalent in terms of rate and extent of absorption.     

Simultaneous LC−UV Analysis of Mirodenafil and Its Two Main Metabolites in Rat Plasma and Urine, and in Tissue Homogenates

A simple, rapid, and reproducible isocratic reversed-phase LC method has been established for simultaneous analysis of mirodenafil and its two main metabolites, SK3541 and SK3544, in rat plasma, urine, and tissue homogenates. Samples were deproteinized with acetonitrile containing sildenafil (internal standard). The compounds were separated on a C₁₈ column with 52:48 (v/v) 0.02 m ammonium acetate buffer (pH 6)—acetonitrile as mobile phase at a flow rate of 1.4 mL min^?1. UV detection was at 254 nm and detection limits of mirodenafil, SK3541, and SK3544 in plasma were 0.03, 0.05, and 0.1 μg mL^?1, respectively. The method is applicable to pharmacokinetic studies of mirodenafil and its metabolites in rats.     

LC Determination of Ritonavir, a HIV Protease Inhibitor, in Soft Gelatin Capsules

A rapid, simple and sensitive high-performance liquid chromatographic method (HPLC) has been developed to assay ritonavir in semisolid capsules. The HPLC analysis used a reversed-phase C₈ (125 × 4.0 mm i.d., 5 μm particle size) analytical column and a mobile phase consisting of methanol and water (67:33, v/v), with UV detection at 210 nm. Specificity was evaluated using a photodiode array detector (PDA). The validation data showed that the assay is sensitive, specific and reproducible for determination of ritonavir in this dosage form. Calibration curves were linear from 100–300 μm L^?1 (R² ≥ 0.999). The accuracy of the method ranged from 98.8 to 102.0%. Mean inter- and intra-assay relative standard deviations (RSD) were less than 1.0%. The proposed method provided an accurate and precise analysis of ritonavir in soft capsules, requiring neither the use of a buffered mobile phase, nor the addition of amine modifiers.     

Simultaneous Determination of Three Flavonoids in Rat Plasma by RP-LC After Oral Administration of the Total Flavonoids of Scutellaria barbata

A liquid chromatographic method for the simultaneous determination of three flavonoids, scutellarin (SCU), isoscutellarein-8-O-glucuronide (ISO) and luteolin (LUT) in rat plasma was developed and validated. Following a single-step liquid–liquid extraction with ethyl acetate, the analytes and internal standard (IS) (rutin) were successfully separated on a Diamonsil C₁₈ column using a mobile phase composed of acetonitrile (A)–0.2% phosphoric acid aqueous solution (B) (0–5 min, 20% A–29% A; 5–25 min, 29% A, v/v) at a flow rate of 1.0 mL min^?1. The linear range was 0.044–2.20 μg mL^?1 for SCU, 0.042–2.08 μg mL^?1 for ISO, and 0.056–2.80 μg mL^?1 for LUT, with the correlation coefficients of 0.9995, 0.9989 and 0.9963, respectively. The limit of quantification of SCU, ISO and LUT were 44, 41.6 and 56 ng mL^?1, respectively. The accuracy of assay was between 88.4 and 103.0%. The inter-day and intra-day precisions (RSD) were less than 10.5%. The developed method was simple, rapid and applied successfully to study the pharmacokinetics of SCU, ISO and LUT after oral administration of the total flavonoids of Scutellaria barbata.     

Validated LC Determination of the Piroxicam-β-Cyclodextrin Inclusion Complex in Tablets and in Human Plasma

A simple, rapid, specific, sensitive HPLC method has been developed for the determination of piroxicam in the tablet dosage form and in human plasma. The method totally eliminates solvent extraction and time-consuming separation procedures. Plasma proteins were precipitated by addition of 3:1 (v/v) acetonitrile-methanol, ZnSO₄, and MgSO₄ and the supernatant was injected directly on to a 250 mm × 4.6 mm, 5 μm particle Spherisorb analytical column. Acetonitrile-methanol-0.04 mol L^?1 KH₂PO_4, 40:10:50 (v/v); pH 3.8, was used as mobile phase. The drug was detected by UV detection at 330 nm. The response was linear over the range of 0.01–10 μg mL^?1 and 0.025–5 μg mL^?1 in mobile phase and human plasma samples, respectively. The proposed method was used without interference from the endogenous substances, for determination of piroxicam in plasma samples obtained from healthy volunteers. The results revealed that the method would be useful in monitoring plasma levels of the drug during pharmacokinetic studies. Assay of piroxicam in its dosage forms for quality-control purposes could also be performed successfully by use of this method.     

High-Performance Liquid Chromatographic Determination of Isofraxidin in Rat Plasma

For the first time a high-performance liquid chromatographic (HPLC) method, with liquid-liquid extraction and ultraviolet (UV) absorbance detection, has been developed for quantification of isofraxidin in rat plasma. The analysis was performed on a Diamonsil C₁₈ column (200 mm × 4.6 mm i.d., 5 μm particle size) with acetonitrile–0.05% phosphoric acid, 26:74 (v/v), as isocratic mobile phase. The linear range was 0.05–8.0 μg mL⁻¹ and the lower limit of quantification was 0.05 μg mL⁻¹. The intra and inter-day relative standard deviation (RSD) for measurement of 0.25, 2.0, and 6.0 μg mL⁻¹ quality-control (QC) samples ranged from 5.7 to 6.4% and from 6.3 to 7.9%, respectively. Accuracy, as relative error (RE), was from ±5.8% to ±7.3%. The method was validated for specificity, accuracy, and precision and was successfully used in a pharmacokinetic study of isofraxidin in rat plasma after administration of Ciwujia extract.     

Determination of Baicalin in Rat Hippocampus by RP-LC After Intravenous Administration of Flavonoids from Scutellariae Radix

A rapid and sensitive method to assay baicalin in rat hippocampus was applied using a simple liquid-liquid extraction technique followed by high-performance liquid chromatography. Baicalin and the internal standard, 4-nitro-benzoic acid, were extracted twice from the homogenized solution with acetonitrile and after centrifugation the combined extracts were evaporated. To the remaining residue 0.1 mL of methanol were added to obtain the sample solution. A 10 μL volume of sample solution was injected onto HPLC for analysis carried out on a Zorbax SB-C₁₈ column using a mobile phase of methanol–water-H₃PO₄ (45:55:0.2, v/v/v, pH 3.0) at 277 nm with a UV detector. The calibration curve for baicalin was linear over the concentration range of 0.05–1.6 μg mg^?1 in hippocampus. Recoveries were reasonable for routine analyses (>88%) and the LOD and LOQ ranged from 0.006 to 0.009 μg mg^?1 and 0.015 to 0.035 μg mg^?1, respectively. The coefficient of variation of the assay precision was less than 5.9%, and the accuracy exceeded 98%. The method was applied to determine the time course of baicalin in rat hippocampus, following the intravenously administration of flavonoids from Scutellariae Radix extract at 90 mg kg^?1 of baicalin to a male Wistar rat. This method provides a very simple, sensitive, and accurate way to determine baicalin concentrations in rat hippocampus.     

Simultaneous Determination of Berberine and Palmatine in Rabbit Plasma by LC-MS–MS and Its Application in Pharmacokinetic Study After Oral Administration of Coptidis and Coptidis–Gardeniae Couple Extract

A valid and sensitive LC-MS–MS method is adopted for pharmacokinetics study of berberine and palmatine in rabbit plasma. After mixing with internal standard tetrahydroberberine, plasma samples were pretreated with 1.5 mL acetonitrile. Chromatographic separation was on a C₁₈ column using a mixture of water (containing 10 mmol L^?1 ammonium acetate, pH 3.5) and acetonitrile (50∶50, v/v) as mobile phase. The detection was performed by selected ion monitoring mode via electrospray ionization source operating in the positive ionization mode. The method was linear over the concentration range of 2.0–200.0 ng mL^?1 for berberine and 1.0–100.0 ng mL^?1 for palmatine. The lowest limits of quantitation (LLOQ) were 2.0 ng mL^?1 for berberine and 1.0 ng mL^?1 for palmatine. The intra- and inter-day precision values were less than 14.3% and the deviations were within ±11.0%. The fully validated LC-MS–MS method has been successfully applied to a pharmacokinetic study of berberine, palmatine in rabbit plasma after oral administration of Coptidis and coptidis–gardeniae couple extract. The results indicated that the plasma profiles of the two compounds in rabbit confirmed to one-compartment open model and the combinational utilization with Gardeniae could increase the bioavailability of berberine and palmatine, the two major active components of Coptidis.     

Chiral Separation of Nateglinide and its L Enantiomer on a Molecularly Imprinted Polymer-Based Stationary Phase

A new chiral stationary phase for nateglinide (N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine) based on a molecularly imprinted polymer has been prepared by non-covalent imprinting. For chromatographic analysis the effects on the separation of mobile phase composition, flow rate, and temperature were investigated, and the optimum conditions for HPLC were shown to be: mobile phase, acetonitrile; flow rate, 0.5 mL min^?1; temperature, 25 °C. It was shown that the nateglinide-imprinted polymer was capable of recognizing the enantiomeric difference between nateglinide and its L enantiomer, whereas the non-imprinted polymer had no such ability. Scatchard analysis was used to investigate the binding characteristics of the nateglinide-imprinted stationary phase; this indicated that two classes of binding site were present in the imprinted polymer. The equilibrium dissociation constant (K _D) and the apparent maximum number (Q _max) of high- and low-affinity binding sites were 3.7 × 10^?4 mol L^?1 and 11.38 μmol g^?1, and 1.81 × 10^?3 mol L^?1 and 27.73 μmol g^?1, respectively.     

LC Determination and Pharmacokinetic Study of Sinomenine in Dog Plasma

A simple HPLC method has been developed for determination of sinomenine in dog plasma and has been used to evaluate the pharmacokinetics of sinomenine tablets in dogs. Chromatographic separation was performed on a reversed-phase column with 0.78% (w/v) NaH₂PO₄-acetonitrile, 88:12 (v/v), as mobile phase, delivered at a flow rate of 1.5 mL min^?1. Detection was performed at 265 nm. The limit of quantification was 5.0 ng mL^?1. The calibration range was from 5.0 to 1000 ng mL^?1. The developed method was applied to pharmacokinetic studies of sinomenine sustained-release tablets (test preparation) and sinomenine conventional tablets (reference preparation) in six dogs. Pharmacokinetic data t _max, C _max, AUC _0-t , AUC _0-∞, and t _1/2 for both preparations were determined from plasma concentration-time profiles. The method was sufficiently sensitive, simple, and repeatable for use in pharmacokinetic studies.     

LC Determination of Curcumin in Dog Plasma for a Pharmacokinetic Study

A rapid, simple, and sensitive high-performance liquid chromatographic method for quantification of curcumin in dog plasma has been developed and validated. After addition of the internal standard (berberine), plasma was acidified and extracted with ethyl acetate. Analysis was performed on a C₁₈ column. The mobile phase was acetonitrile–5% acetic acid, 52:48 (v/v) and the flow rate 1.0 mL min^?1. The eluent was monitored at 425 nm. Chromatographic separation was achieved in less than 7 min and the calibration plot was linear over the concentration range 2–128 ng mL^?1. Intra- and inter-assay variability were less than 7.3%. The accuracy ranged from 98.7 to 105.0%. The method was successfully applied to a pharmacokinetic study of curcumin in dogs.     

LC Determination and Pharmacokinetics Study of Mangiferin in Rat Plasma and Tissues

An LC method was developed for determination of mangiferin in rat plasma and tissues after oral administration of Rhizoma Anemarrhenae extract. Analysis was performed on a Gemini C₁₈ analytical column (250 × 4.6 mm, i.d.) with mobile phase consisting of acetonitrile–water (23:77, v/v) with 1% acetic acid and 1% tetrahydrofuran at a flow rate of 0.7 mL min^?1. Spinosin was used as internal standard and UV detector was set at 320 nm. The calibration curve of mangiferin in rat plasma and tissues showed excellent linear behaviors over the investigated concentration ranges with the value of R ² higher than 0.994. The within-day and between-day precisions for all samples were measured to be below 11.0%. The limit of quantitation was low enough for determination of mangiferin in all samples. After Rhizoma Anemarrhenae extract was orally administered to rats, the main pharmacokinetic parameters of mangiferin T _max, C _max, T _0.5α , T _0.5β , AUC_0 ? T and Vc were 4.20 h, 9.52 μg mL^?1, 1.21 h, 1.71 h, 29.9 mg h L^?1 and 0.18 L kg^?1, respectively. Mangiferin was extensively distributed in most of the main tissues of rats. This validated method has been successfully applied to preliminary pharmacokinetics and tissue distribution study of mangiferin in rats.     

Simultaneous Analysis of Zofenopril and Its Active Metabolite Zofenoprilat in Human Plasma by LC–ESI-MS Using Pre-Column Derivatization with p-Bromophenacyl Bromide

Zofenoprilat is an active metabolite of zofenopril, which is very unstable in plasma because of oxidative degradation of its thiol group. In this method, p-bromophenacyl bromide was used as derivatization reagent, immediately after plasma separation, to react with the free thiol group of zofenoprilat and form the derivative zofenoprilat-p-BPB. After acidification with 50% acetic acid, the derivatized plasma samples were extracted with methyl tert-butyl ether and separated on a C₁₈ column with 40:60 (v/v) 10 mM ammonium acetate buffer solution containing 0.1% formic acid–acetonitrile as mobile phase. Calibration plots were linear over the concentration range 1–500 ng mL^?1 for zofenopril and 2–1,800 ng mL^?1 for zofenoprilat. The method was successfully used to study the bioavailability of zofenopril calcium capsules relative to that of zofenopril calcium tablets in healthy Chinese volunteers.     

RP-LC Determination of Residual Monomers in Polycarboxylate Superplasticizers

A procedure was developed for the determination of residual monomers in polycarboxylate superplasticizer by reversed-phase high performance liquid chromatography. Seven kinds of residual monomers were quantitatively determined on a SinoChrom ODS-BP (C18) column and UV detector at 205 nm. The mobile phases which were used to determine micromolecular monomers were composed of acetonitrile and phosphate buffer solution (0.05 mol L^?1, pH = 3) in the ratio of 8:92 (v/v). While the mobile phases for long side-chain monomers testing were composed of acetonitrile and phosphate buffer solution (0.05 mol L^?1, pH = 6.5) in the ratio of 40:60 (v/v). The linear response ranged from 4.0 × 10^?6?C2.0 × 10^?3 mol L^?1. The detection limit was 0.12 × 10^?5?C0.8 × 10^?5 mol L^?1. Determination of real samples showed that relative standard deviation of high conversion rate samples was 3.1?C8.7% and standard addition recovery ratio was 91.5?C102.8%. While the relative standard deviation of low conversion rate samples was less than or close to 1% and the standard addition recovery ratio was 96.3?C103.1%.     

Highly sensitive electrocatalytic determination of pyrazinamide using a modified poly(glycine) glassy carbon electrode by square-wave voltammetry

A new voltammetric sensor based on electropolymerization of glycine at glassy carbon electrode (GCE) was developed and applied to determine of pyrazinamide (PZA) by square-wave voltammetry (SWV). The initial cyclic voltammetric studies showed an electrocatalytic activity of poly(Gly)/GCE on redox system of pyrazinamide in 0.1 mol L^?1 phosphate buffer solution pH 7.5, with E _Pc and E _Pa in ?0.85 and ?0.8 V (versus E _Ag/AgCl), respectively. Studies at different scan rates suggest that the redox system of pyrazinamide at poly(Gly)/GCE is a process controlled by diffusion in the interval from 10 to 100 mV s^?1. Square-wave voltammetry-optimized conditions showed a linear response of PZA concentrations in the range from 0.47 to 6.15 μmol L^?1 (R?=?0.998) with a limit of detection (LOD) of 0.035 μmol L^?1 and a limit of quantification (LOQ) of 0.12 μmol L^?1. The developed SWV-poly(Gly)/GCE method provided a good intra-day (RSD?=?3.75 %) and inter-day repeatability (RSD?=?4.96 %) at 4.06 μmol L^?1 PZA (n?=?10). No interference of matrix of real samples was observed in the voltammetric response of PZA, and the method was considered to be highly selective for the compound. In the accuracy test, the recovery was found in the range of 98.2 and 104.0 % for human urine samples and pharmaceutical formulation (tablets). The PZA quantification results in pharmaceutical tablets obtained by the proposed SWV-poly(Gly)/GCE method were comparable to those found by official analytical protocols.     

Use of Surfactant as Mobile Phase Additive in LC for Simultaneous Determination of Metal-Pyrrolidine Dithiocarbamate Chelates

Reversed phase liquid chromatography using UV detection was developed for the simultaneous analysis of Hg(II), Pb(II), Cd(II), Ni(II), Fe(III) and V(V) ions after their complexation with pyrrolidine-dithiocarbamate (PDC). Optimum chromatographic conditions were a μ-Bondapak C₁₈ column and an isocratic mobile phase consisting of 40 mmol L^?1 SDS, 34 mmol L^?1 TBABr and 68% acetonitrile in 10 mmol L^?1 phosphate buffer pH 3.5. The separation of six PDC complexes was achieved within 8 min. Analytical performances and method validation were investigated. The detection limits ranged from 0.16 μg L^?1(Fe(III)) to 5.40 μg L^?1(Pb(II)). Recoveries obtained for all the studied samples including tap water, whole blood and vegetables were 72–98%. The results obtained from the proposed method were not significantly different compared to those obtained from atomic absorption spectrometry (P = 0.05).